Health & Wellness Research · Jun 13, 2026 Daily Digest
FDA Drug Label Updates
- 🔥 Semaglutide: New safety warnings about gastrointestinal side effects have been added to prescribing information.
- 🔥...

Created by Jinze Gu
Timely FDA, CDC, and Recalls.gov alerts on drugs, devices, and vaccines for specific populations
Explore the latest content tracked by Health & Wellness Research
The FDA updated Alli's label after 12 reported kidney complications from 2007-2023, including acute kidney injury, oxalate nephropathy, and stones,...
Common blood pressure medications carry specific safety concerns for seniors that often go overlooked.
The FDA announced a voluntary recall of Farm Rich Pizza Cheese Crunchers due to possible metal contamination.
Medical device malfunctions are drawing legal and regulatory heat:
ACIP changes are removing universal vaccine recommendations without new evidence, shifting some to shared clinical decisions and creating ambiguity...
Staying on track with your child's vaccines protects them at key ages.
FDA actions highlight rising dangers from unregulated compounded and counterfeit semaglutide/tirzepatide.
GLP-1 drugs carry layered risks that cheap options often ignore.
Gen Z men are rapidly adopting unregulated peptides for fitness and wellness, with many compounds appearing on FDA 'do not use' lists.
Many arrhythmia therapy studies report zero adverse events, with serious events at 2-6% and other events at 3-13% across categories. This pattern...
A multistate Salmonella outbreak linked to moringa leaf powder and capsules has sickened 119 people across 36 states, with 32 hospitalizations....
The FDA has added a kidney injury warning to the alli weight loss drug after reviewing 12 cases of kidney complications linked to orlistat use. Consumers using this OTC product should review the updated label for new safety details.
The Hintermann ankle replacement shows a 16.1% failure rate in post-approval data, triggering a new FDA warning. Patients evaluating ankle replacement should weigh this risk and recognize the value of ongoing surveillance.
Parents need clear facts on the a2 recall amid reassuring FDA data.
Novo Nordisk is suing South African compounder iDexis to halt sales of unregistered semaglutide copies, citing patient safety, quality risks, and lack...
FDA updated alli (orlistat 60 mg) labeling to warn of rare acute kidney injury and kidney stones.